The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies

BACKGROUND: High-grade primary and metastatic central nervous system (CNS) tumors are common, deadly, and refractory to conventional therapy and continue to be therapeutically challenging. A key nodal transcriptional factor, the signal transducer and activator of transcription 3 (STAT3), drives the...

Descripción completa

Detalles Bibliográficos
Autor principal: Heimberger, Amy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228387/
https://www.ncbi.nlm.nih.gov/pubmed/22140648
http://dx.doi.org/10.4103/2152-7806.89886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228387/
https://www.ncbi.nlm.nih.gov/pubmed/22140648
http://dx.doi.org/10.4103/2152-7806.89886

Ejemplares similares